Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Scholar Rock < Previous 1 2 3 Next > Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 13, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity September 10, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer September 04, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock to Participate in Upcoming Investor Conferences August 29, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 16, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress August 08, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 July 23, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 12, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal June 24, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 18, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting June 03, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting May 28, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity May 22, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock to Participate in Upcoming Investor Conferences May 20, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 17, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock to Host Investor Day on May 22, 2024 May 14, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress May 07, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 12, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress March 19, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock to Participate in Upcoming Investor Conferences February 28, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 16, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer February 15, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management February 06, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia January 25, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity January 23, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 12, 2024 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference December 19, 2023 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 15, 2023 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 17, 2023 From Scholar Rock Via Business Wire Tickers SRRK Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability November 03, 2023 From Scholar Rock Via Business Wire Tickers SRRK < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.